Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Malignancies

Explore clinical trials studying Advanced Solid Malignancies. Study availability and eligibility vary by location and protocol.

48 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Malignancies trial results

Active, not recruiting

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

NCT05159700

Conditions
Advanced Solid Malignancies, Advanced Solid Tumor, Congenital Abnormalities, +10 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • NEXT Oncology Austin, Texas, United States
View Trial Details
Active, not recruiting

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

NCT04521413

Conditions
Advanced Solid Malignancies
Locations
  • University of California San Diego La Jolla, California, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 13 locations
View Trial Details
Completed

A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

NCT02740985

Conditions
Advanced Solid Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Research Site Fayetteville, Arkansas, United States
  • Research Site Fresno, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site New Haven, Connecticut, United States
View all 17 locations
View Trial Details
Completed

An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.

NCT03084471

Conditions
Advanced Solid Malignancies, Diabetes Mellitus, Insulin-Dependent, 12
Locations
  • Research Site Santa Rosa, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Tinley Park, Illinois, United States
  • Research Site Omaha, Nebraska, United States
View all 79 locations
View Trial Details

Related conditions